Targeting our efforts: the contribution of an open-access tool to assess geographic distribution of recurrent and metastatic cervical cancer

Gynecol Oncol. 2023 Feb:169:A1-A2. doi: 10.1016/j.ygyno.2023.01.028.

Authors

Teresa K L Boitano¹, Isabel C Scarinci²

Affiliations

¹ Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: tlboitano@uabmc.edu.
² Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

PMID: 36774049
DOI: 10.1016/j.ygyno.2023.01.028

No abstract available

Publication types

Editorial

MeSH terms

Female
Humans
Neoplasm Recurrence, Local / epidemiology
Neoplasm Recurrence, Local / pathology
Paclitaxel
Uterine Cervical Neoplasms* / pathology

Substances

Paclitaxel